Cardiovascular Medicine, Stanford University, Stanford, California, USA.
Curr Opin Organ Transplant. 2022 Feb 1;27(1):52-56. doi: 10.1097/MOT.0000000000000940.
There is limited data and guidance on donor selection for multiorgan transplantation. In this article, we review the current Organ Procurement and Transplantation Network policy on multiorgan allocation and the ideal donor criteria for each specific organ, in order to provide a framework to guide donor selection for various scenarios of multiorgan transplantation, including heart-kidney, heart-lung, heart-liver and heart-kidney-liver transplant procedures.
Combined heart-kidney transplantation is the most common multiorgan transplant procedure and requires the most stringent HLA matching to ensure optimal graft survival. Using the virtual crossmatch and desensitization therapies can shorten waitlist times without increasing posttransplant rejection or mortality rates. The ideal heart-lung donor tends to be younger than other multiorgan transplants, and more tolerant to HLA mismatch, but ideally requires donors with no prior history of smoking, a short period of time on mechanical ventilation, adequate oxygenation and absence of pulmonary infection. The ideal heart-liver donor is often driven by criteria specific to the donor heart. Finally, several observational studies suggest that livers are more tolerant to HLA mismatch than other organs, and offer some degree of immune protection in combined organ transplants.
Multiorgan transplantation is a steadily growing field. The required short ischemic time for the donor heart is often the limiting factor, as well as the scarcity of appropriate donors available within geographical confines. In general, as with single organ transplantation, younger age, size matching, few medical comorbidities and HLA compatibility confer the best posttransplant outcomes.
多器官移植的供体选择数据有限,指导亦有限。本文回顾了目前器官获取与移植网络(Organ Procurement and Transplantation Network)关于多器官分配的政策和每个特定器官的理想供体标准,旨在为各种多器官移植场景下的供体选择提供框架,包括心脏-肾脏、心脏-肺、心脏-肝脏和心脏-肾脏-肝脏移植程序。
心脏-肾脏联合移植是最常见的多器官移植程序,需要最严格的 HLA 匹配,以确保最佳移植物存活率。使用虚拟交叉配型和脱敏治疗可以缩短等待名单时间,而不会增加移植后排斥反应或死亡率。理想的心脏-肺供体往往比其他多器官移植更年轻,对 HLA 不匹配的耐受性更强,但理想情况下需要没有吸烟史、机械通气时间短、氧合充足且没有肺部感染的供体。理想的心脏-肝脏供体通常由供体心脏的特定标准驱动。最后,几项观察性研究表明,肝脏比其他器官更能耐受 HLA 不匹配,并在联合器官移植中提供一定程度的免疫保护。
多器官移植是一个稳步发展的领域。供体心脏所需的短缺血时间通常是限制因素,此外,在地理范围内,合适的供体稀缺。一般来说,与单器官移植一样,年龄较小、大小匹配、较少的合并症和 HLA 相容性可带来最佳的移植后效果。